Tue, 10 Sep 2019 12:28:35 GMT
Mallinckrodt set for BioVectra uni sale in $250M deal
On Tuesday, Mallinckrodt Plc stated it was set for its BioVectra unit sale to the private equity group H.I.G. Capital in a deal worth up to $250M, after the drugmaker played down its bankruptcy concerns due to opioid litigation uncertainties.